(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ALGERNON

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ALGERNON

ST13

US500000088505722

Classe

5

Pedido

88505722

Registro

8064250

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

86

Atualização mais recente

17/12/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5

Data de depósito

09/07/2019

Data de registro

16/12/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

16/12/2025

Última transação

17/12/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

VANCOUVER, BC, CA

Examinador

FRIEDMAN,LESLEE ANN

Unidade examinadora

N20

Localização atual

INTENT TO USE SECTION

Titulares e representantes

Titulares

ALGERNON PHARMACEUTICALS INC.
Breathtec Biomedical Inc.

Representantes

Nicholas J. Gingo RENNER, OTTO, BOISSELLE & SKLAR, LLP

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceuticals for use in the treatment of kidney diseasesliver diseasesinflammatory bowel diseases and pulmonary diseases namely coughs and lung cancer

Publicações

Histórico de despachos e eventos da marca no USPTO.

86 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

16/12/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

16/12/2025

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

21/11/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

21/11/2025

IUCN

NOTICE OF ALLOWANCE CANCELLED

01/10/2025

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

01/10/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

26/04/2025

EX1G

SOU EXTENSION 1 GRANTED

25/04/2025

EXT1

SOU EXTENSION 1 FILED

25/04/2025

EEXT

SOU TEAS EXTENSION RECEIVED

25/04/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

29/10/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/09/2024

PUBO

PUBLISHED FOR OPPOSITION

03/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

14/08/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

29/07/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

29/07/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

29/07/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

29/07/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

29/07/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

29/04/2024

GNFR

FINAL REFUSAL E-MAILED

29/04/2024

CNFR

FINAL REFUSAL WRITTEN

29/04/2024

DOCK

ASSIGNED TO EXAMINER

03/04/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

27/03/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

27/03/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

26/03/2024

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

23/01/2024

GNSI

INQUIRY TO SUSPENSION E-MAILED

23/01/2024

CNSI

SUSPENSION INQUIRY WRITTEN

23/01/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

10/01/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/06/2023

GNSL

LETTER OF SUSPENSION E-MAILED

02/06/2023

CNSL

SUSPENSION LETTER WRITTEN

02/06/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/06/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/06/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

31/05/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

06/03/2023

GNSI

INQUIRY TO SUSPENSION E-MAILED

06/03/2023

CNSI

SUSPENSION INQUIRY WRITTEN

06/03/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/08/2022

GNSL

LETTER OF SUSPENSION E-MAILED

04/08/2022

CNSL

SUSPENSION LETTER WRITTEN

04/08/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

28/07/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

28/07/2022

ALIE

ASSIGNED TO LIE

28/07/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

26/07/2022

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

20/07/2022

GNSI

INQUIRY TO SUSPENSION E-MAILED

20/07/2022

CNSI

SUSPENSION INQUIRY WRITTEN

20/07/2022

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

24/06/2022

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

03/06/2022

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/05/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/09/2021

GNSL

LETTER OF SUSPENSION E-MAILED

02/09/2021

CNSL

SUSPENSION LETTER WRITTEN

02/09/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/09/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/09/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

25/08/2021

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

02/08/2021

GNSI

INQUIRY TO SUSPENSION E-MAILED

02/08/2021

CNSI

SUSPENSION INQUIRY WRITTEN

02/08/2021

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

22/07/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

21/09/2020

GNSL

LETTER OF SUSPENSION E-MAILED

21/09/2020

CNSL

SUSPENSION LETTER WRITTEN

21/09/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

15/09/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

15/09/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/09/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

29/04/2020

GNSI

INQUIRY TO SUSPENSION E-MAILED

29/04/2020

CNSI

SUSPENSION INQUIRY WRITTEN

29/04/2020

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

29/04/2020

ALIE

ASSIGNED TO LIE

28/04/2020

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

18/12/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

07/10/2019

GNSL

LETTER OF SUSPENSION E-MAILED

07/10/2019

CNSL

SUSPENSION LETTER WRITTEN

07/10/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/10/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/10/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/10/2019

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

02/10/2019

GPRA

PRIORITY ACTION E-MAILED

02/10/2019

CPRA

PRIORITY ACTION WRITTEN

02/10/2019

DOCK

ASSIGNED TO EXAMINER

25/09/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

16/07/2019

NWAP

NEW APPLICATION ENTERED

12/07/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ALGERNON ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.